Chris Takimoto
Board Member
Alx Oncology Holdings Inc (ALXO)Equibles does not estimate personal net worth.
Get an email with a short summary when Alx Oncology Holdings Inc publishes a filing, an earnings call transcript or a press release.
Get ALXO alertsAbout Chris Takimoto
Chris Takimoto is recorded as Board Member at Alx Oncology Holdings Inc (ALXO). The newest filing on record that lists Chris Takimoto as Board Member at Alx Oncology Holdings Inc (ALXO) is dated April 20, 2026. Alx Oncology Holdings Inc reported in an 8-K filed January 22, 2025 that Chris Takimoto was appointed Class III director, effective January 18, 2025. Alx Oncology Holdings Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alx Oncology Holdings Inc includes Jason Lettmann (CEO and Board Member), Scott Garland (Chairman and Board Member), Harish Shantharam (CFO) and 7 others.
“Effective January 18, 2025, the Board appointed Barbara Klencke, M.D. to serve as a Class II director of the Board, for a term expiring at the 2025 annual meeting of stockholders, and Chris Takimoto, M.D., Ph.D., F.A.C.P., to serve as a Class III director of the Board, for a term expiring at the 2026 annual meeting of stockholders.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 20, 2026
Company network
Leadership on record at Alx Oncology Holdings Inc
- Jason Lettmann CEO, Board Member
- Scott Garland Chairman, Board Member
- Harish Shantharam CFO
- Michael Listgarten General Counsel
- Shelly Wong Chief Accounting Officer
- Alan Sandler Board Member
- Alan Sandler, M.D. Board Member
- Barbara Klencke Board Member
- Continuing Directors Board Member
- Daniel Curran Board Member